Literature DB >> 2965765

Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells.

D H Maul1, C P Zaiss, M R MacKenzie, S M Shiigi, P A Marx, M B Gardner.   

Abstract

Simian acquired immunodeficiency syndrome is a fatal immunosuppressive disease caused by type D retroviruses such as simian acquired immunodeficiency syndrome retrovirus type 1 (SRV-1). The disease is characterized by generalized lymphadenopathy, opportunistic infections, and lymphoid depletion with defects in both humoral and cell-mediated immunity. To understand how SRV-1 infection relates to the immune defect, we studied in vivo-infected lymphocytes from SRV-1-positive macaques with and without clinical signs of immunosuppressive disease. B and T helper/inducer and T suppressor/cytotoxic lymphocytes were purified by panning or by flow cytometry. Neutrophils were purified by dextran sedimentation, and platelets were purified by low-speed centrifugation. In vitro infection studies were also done with HUT78, H9, K562, rhesus lung fibroblast, rhesus monkey kidney, and bat lung cells. SRV-1 in lymphocytes or culture supernatants was detected by the induction of syncytia in cocultivated Raji cells and was confirmed by immunofluorescence, electron microscopy, or reverse transcriptase assay. We found that B and T helper/inducer lymphocytes were infected in all animals tested. The number of infected T suppressor/cytotoxic cells was generally lower than that of the other cell subsets, and not all animals in this subset had SRV-1 infections. All other cells exposed in vitro to SRV-1, except bat lung cells, were able to be infected. These findings show that SRV-1 has a broad cell tropism for lymphoid and nonlymphoid cell types.

Entities:  

Mesh:

Year:  1988        PMID: 2965765      PMCID: PMC253224     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Induction of simian acquired immune deficiency syndrome (SAIDS) with a molecular clone of a type D SAIDS retrovirus.

Authors:  G Heidecker; N W Lerche; L J Lowenstine; A A Lackner; K G Osborn; M B Gardner; P A Marx
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

3.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  A multipotential leukemia cell line (K-562) of human origin.

Authors:  B B Lozzio; C B Lozzio; E G Bamberger; A S Feliu
Journal:  Proc Soc Exp Biol Med       Date:  1981-04

5.  A new type D retrovirus isolated from macaques with an immunodeficiency syndrome.

Authors:  M D Daniel; N W King; N L Letvin; R D Hunt; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1984-02-10       Impact factor: 47.728

6.  Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions.

Authors:  N Nathanson; H Panitch; P A Palsson; G Petursson; G Georgsson
Journal:  Lab Invest       Date:  1976-11       Impact factor: 5.662

7.  Enrichment (and depletion) of human suppressor cells with monoclonal antibodies and immunoglobulin-coated plates.

Authors:  M S Tsoi; J Aprile; S Dobbs; S Goehle; R Storb
Journal:  J Immunol Methods       Date:  1982-09-30       Impact factor: 2.303

8.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease.

Authors:  M B Oldstone; F J Dixon
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

10.  Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.

Authors:  J E Gootenberg; F W Ruscetti; J W Mier; A Gazdar; R C Gallo
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  16 in total

1.  Acquired amegakaryocytic thrombocytopenia purpura in a Rhesus macaque (Macaca mulatta).

Authors:  Patrick W Hanley; Wallace B Baze; Mark J McArthur; Bruce J Bernacky; Greg K Wilkerson; Kirstin F Barnhart
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

2.  Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Authors:  N W Lerche; W M Switzer; J L Yee; V Shanmugam; A N Rosenthal; L E Chapman; T M Folks; W Heneine
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destruction.

Authors:  Rajeev Gautam; Arun Iyer; Meredith Hunter; Arpita Das; Tessa Williams; Jason Dufour; Cristian Apetrei; K Gus Kousoulas; Preston A Marx
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

4.  Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.

Authors:  S Sutjipto; N C Pedersen; C J Miller; M B Gardner; C V Hanson; A Gettie; M Jennings; J Higgins; P A Marx
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques.

Authors:  S V Joag; Z Li; L Foresman; E B Stephens; L J Zhao; I Adany; D M Pinson; H M McClure; O Narayan
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  The RD114/simian type D retrovirus receptor is a neutral amino acid transporter.

Authors:  J E Rasko; J L Battini; R J Gottschalk; I Mazo; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Localization of the receptor gene for type D simian retroviruses on human chromosome 19.

Authors:  M A Sommerfelt; B P Williams; A McKnight; P N Goodfellow; R A Weiss
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys.

Authors:  A A Lackner; M O Smith; R J Munn; D J Martfeld; M B Gardner; P A Marx; S Dandekar
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

9.  Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2.

Authors:  C C Tsai; K E Follis; M Yarnall; G A Blakley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Persistence and dissemination of simian retrovirus type 2 DNA in relation to viremia, seroresponse, and experimental transmissibility in Macaca fascicularis.

Authors:  Roseanne C Wilkinson; Claire K Murrell; Rebecca Guy; Gail Davis; Joanna M Hall; David C North; Nicola J Rose; Neil Almond
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.